Hinge Health, Inc. (HNGE)
NYSE: HNGE · Real-Time Price · USD
46.14
+0.30 (0.65%)
At close: Mar 6, 2026, 4:00 PM EST
46.13
-0.01 (-0.02%)
After-hours: Mar 6, 2026, 7:00 PM EST
Hinge Health Stock Forecast
Stock Price Forecast
The 16 analysts with 12-month price forecasts for Hinge Health stock have an average target of 58.25, with a low estimate of 45 and a high estimate of 70. The average target predicts an increase of 26.25% from the current stock price of 46.14.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Hinge Health stock from 17 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 6 | 6 |
| Buy | 9 | 9 | 9 | 9 | 10 | 10 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 15 | 15 | 17 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $65 → $53 | Strong Buy | Maintains | $65 → $53 | +14.87% | Feb 11, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $60 → $50 | Buy | Maintains | $60 → $50 | +8.37% | Feb 11, 2026 |
| Citizens | Citizens | Buy Reiterates $65 | Buy | Reiterates | $65 | +40.88% | Feb 11, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $65 → $50 | Buy | Maintains | $65 → $50 | +8.37% | Feb 11, 2026 |
| Barclays | Barclays | Buy Maintains $60 → $52 | Buy | Maintains | $60 → $52 | +12.70% | Feb 11, 2026 |
Financial Forecast
Revenue This Year
753.50M
from 587.86M
Increased by 28.18%
Revenue Next Year
894.00M
from 753.50M
Increased by 18.65%
EPS This Year
1.93
from -7.77
EPS Next Year
2.31
from 1.93
Increased by 19.68%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 782.6M | 960.8M | |||
| Avg | 753.5M | 894.0M | |||
| Low | 719.7M | 832.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 33.1% | 27.5% | |||
| Avg | 28.2% | 18.6% | |||
| Low | 22.4% | 10.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 2.63 | 3.24 | |||
| Avg | 1.93 | 2.31 | |||
| Low | 1.00 | 1.37 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 68.1% | |||
| Avg | - | 19.7% | |||
| Low | - | -28.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.